To evaluate the impact of antithrombotic regimens during the medical phase of treatment among 13,819 patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) treated with an early invasive strategy in the acute catheterization and urgent intervention triage strategy (ACUITY) trial.status: publishe
Background: Patients with non–ST-segment elevation acute coro-nary syndrome (ACS) are managed with e...
Background-Early invasive strategies and antithrombotic treatments are key treatments of non-ST-segm...
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superio...
AIM: To evaluate the impact of antithrombotic regimens during the medical phase of treatment among 1...
Contains fulltext : 224898.pdf (publisher's version ) (Open Access)In the current ...
This study evaluated the impact of nonculprit vessel myocardial perfusion on outcomes of non-ST-segm...
We evaluated patients at tertiary [both percutaneous coronary intervention (PCI) and coronary artery...
Anticoagulant therapy during the acute phase of non-ST elevation acute coronary syndromes (NSTE-ACS)...
© 2018 Elsevier Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license: h...
"Context The American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the ...
Despite the increasing use of early invasive strategies in non-ST-elevation acute coronary syndromes...
Background-Outcomes of patients presenting with acute coronary syndromes are improved with an early ...
ObjectivesWe sought to characterize the utilization and impact of a conservative medical management ...
# The Author(s) 2013. This article is published with open access at Springerlink.com The most common...
To describe international patterns and opportunities for improvement of pre- and in-hospital care of...
Background: Patients with non–ST-segment elevation acute coro-nary syndrome (ACS) are managed with e...
Background-Early invasive strategies and antithrombotic treatments are key treatments of non-ST-segm...
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superio...
AIM: To evaluate the impact of antithrombotic regimens during the medical phase of treatment among 1...
Contains fulltext : 224898.pdf (publisher's version ) (Open Access)In the current ...
This study evaluated the impact of nonculprit vessel myocardial perfusion on outcomes of non-ST-segm...
We evaluated patients at tertiary [both percutaneous coronary intervention (PCI) and coronary artery...
Anticoagulant therapy during the acute phase of non-ST elevation acute coronary syndromes (NSTE-ACS)...
© 2018 Elsevier Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license: h...
"Context The American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the ...
Despite the increasing use of early invasive strategies in non-ST-elevation acute coronary syndromes...
Background-Outcomes of patients presenting with acute coronary syndromes are improved with an early ...
ObjectivesWe sought to characterize the utilization and impact of a conservative medical management ...
# The Author(s) 2013. This article is published with open access at Springerlink.com The most common...
To describe international patterns and opportunities for improvement of pre- and in-hospital care of...
Background: Patients with non–ST-segment elevation acute coro-nary syndrome (ACS) are managed with e...
Background-Early invasive strategies and antithrombotic treatments are key treatments of non-ST-segm...
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superio...